ADIM
ENB icon

Alpha DNA Investment Management’s Enbridge ENB Stock Holding History

Alpha DNA Investment Management’s Portfolio ENB Stock Details ENB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-134
Closed -$4K – 267
2021
Q1 		$4K Hold
134
– – ﹤0.01% 404
2020
Q4 		$4K Buy
+134
New +$4.08K ﹤0.01% 389

Other funds holding ENB

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Alpha DNA Investment Management's ENB Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Enbridge (ENB) in Q2 2021, closing a stake of 134 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in ENB in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 1,109 funds tracked by Wall St. Rank hold ENB as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Enbridge position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 134 Enbridge shares in Q2 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in Enbridge in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Enbridge position peaked at $4K in Q1 2021.
  • 1,109 funds tracked by Wall St. Rank held Enbridge as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.